カテゴリ： DelveInsight, EP2016, 世界, 医療/バイオ

移植片対宿主病（GVHD）治療薬の世界市場：市場インサイト、疫学、市場予測

◆英語タイトル：Graft versus host disease (GVHD)- Market Insights, Epidemiology and Market Forecast-2023
◆商品コード：DLVEP06123
◆発行会社（リサーチ会社）：DelveInsight
◆発行日：2016年8月
◆ページ数：約100
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後10営業日）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名使用）USD4,950 ⇒換算￥514,800見積依頼/購入/質問フォーム
Site Price（同一国内共有可）USD9,900 ⇒換算￥1,029,600見積依頼/購入/質問フォーム
Enterprise Price（複数国内共有可）USD14,850 ⇒換算￥1,544,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※DelveInsight社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
当調査レポートでは、移植片対宿主病（GVHD）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。
・移植片対宿主病（GVHD）の概要
・病態生理
・移植片対宿主病（GVHD）の症状
・移植片対宿主病（GVHD）の病因
・移植片対宿主病（GVHD）の診断
・移植片対宿主病（GVHD）の治療
・上市品の概要
・医薬品の説明
・作用機序
・薬物動態学的特性
・特許情報
・移植片対宿主病（GVHD）の疫学分析
・移植片対宿主病（GVHD）治療薬の世界市場規模
・移植片対宿主病（GVHD）治療薬の世界市場予測
・移植片対宿主病（GVHD）治療薬のアメリカ市場規模
・移植片対宿主病（GVHD）治療薬のアメリカ市場予測
・移植片対宿主病（GVHD）治療薬のヨーロッパ市場規模
・移植片対宿主病（GVHD）治療薬のヨーロッパ市場予測
（ドイツ、イギリス、フランス、イタリア、スペイン）
・移植片対宿主病（GVHD）治療薬の日本市場規模
・移植片対宿主病（GVHD）治療薬の日本市場予測
【レポートの概要】

Note*: This report requires 7-10 business days to complete.
DelveInsight’s Graft versus host disease (GVHD) – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Graft versus host disease (GVHD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Graft versus host disease (GVHD) till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Graft versus host disease (GVHD) market.
• Identifying patient populations in the global “Graft versus host disease (GVHD)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Graft versus host disease (GVHD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Graft versus host disease (GVHD) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Graft versus host disease (GVHD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

【レポートの目次】

Table of Contents

• Graft versus host disease (GVHD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Graft versus host disease (GVHD) Market
• Global Epidemiology of Graft versus host disease (GVHD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight

List of Tables

• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Graft versus host disease (GVHD) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Graft versus host disease (GVHD) (2013-2023)
• Table 7: Graft versus host disease (GVHD) Global Market (USD Millions), (2013-2015)
• Table 8: Graft versus host disease (GVHD) Global Market (USD Millions), (2016-2023)
• Table 9: Graft versus host disease (GVHD) US Market (USD Millions), (2013-2015)
• Table 10: Graft versus host disease (GVHD) US Market (USD Millions), (2016-2023)
• Table 11: Graft versus host disease (GVHD) Germany Market (USD Millions), (2013-2015)
• Table 12: Graft versus host disease (GVHD) Germany Market (USD Millions), (2016-2023)
• Table 13: Graft versus host disease (GVHD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Graft versus host disease (GVHD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Graft versus host disease (GVHD) France Market (USD Millions), (2013-2015)
• Table 16: Graft versus host disease (GVHD) France Market (USD Millions), (2016-2023)
• Table 17: Graft versus host disease (GVHD) Italy Market (USD Millions), (2013-2015)
• Table 18: Graft versus host disease (GVHD) Italy Market (USD Millions), (2016-2023)
• Table 19: Graft versus host disease (GVHD) Spain Market (USD Millions), (2013-2015)
• Table 20: Graft versus host disease (GVHD) Spain Market (USD Millions), (2016-2023)
• Table 21: Graft versus host disease (GVHD) Japan Market (USD Millions), (2013-2015)
• Table 22: Graft versus host disease (GVHD) Japan Market (USD Millions), (2016-2023)
• Table 23: Graft versus host disease (GVHD) ROW Market (USD Millions), (2013-2015)
• Table 24: Graft versus host disease (GVHD) ROW Market (USD Millions), (2016-2023)

List of Figures

• Figure 1: Graft versus host disease (GVHD) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Graft versus host disease (GVHD) (2013-2023)
• Figure 3: Graft versus host disease (GVHD) Global Market (USD Millions), (2013-2015)
• Figure 4: Graft versus host disease (GVHD) Global Market (USD Millions), (2016-2023)
• Figure 5: Graft versus host disease (GVHD) US Market (USD Millions), (2013-2015)
• Figure 6: Graft versus host disease (GVHD) US Market (USD Millions), (2016-2023)
• Figure 7: Graft versus host disease (GVHD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Graft versus host disease (GVHD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Graft versus host disease (GVHD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Graft versus host disease (GVHD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Graft versus host disease (GVHD) France Market (USD Millions), (2013-2015)
• Figure 12: Graft versus host disease (GVHD) France Market (USD Millions), (2016-2023)
• Figure 13: Graft versus host disease (GVHD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Graft versus host disease (GVHD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Graft versus host disease (GVHD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Graft versus host disease (GVHD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Graft versus host disease (GVHD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Graft versus host disease (GVHD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Graft versus host disease (GVHD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Graft versus host disease (GVHD) ROW Market (USD Millions), (2016-2023)



【掲載企業】

• Sanofi
• Novartis
• Neovii
• J&J
• Merck
• Amgen
• Eisai
• BMS
• Astellas Pharma
• Genzyme
• Roche
• Pfizer
• Millenium Pharmaceuticals
• Warner Lambert
• Hospira
• Jazz Pharmaceuticals
• Adienne Pharma
• Dr Falk Pharma
• Mesoblast
• Osiris
• Athersys
• Therakos
• Soligenix

【レポートのキーワード】

移植片対宿主病（GVHD）

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[移植片対宿主病（GVHD）治療薬の世界市場：市場インサイト、疫学、市場予測]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 移植片対宿主病（GVHD）治療薬の世界市場：市場インサイト、疫学分析、市場予測
    DLVE704004 / DelveInsight / 2017年1月 / ...DelveInsight’s “Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023” report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for the forecast period (2013-2023). The report also includes global market size of the Graft Versus Host Disease (GVHD) for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan.GVHD is one of the severe complications associated...
  2. 移植片対宿主病（GVHD）治療薬のアメリカ市場：市場インサイト、疫学分析、市場予測
    DLVE704016 / DelveInsight / 2017年1月 / ...DelveInsight’s “Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023-United States” report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for the forecast period (2013-2023). The report also includes global market size of the Graft Versus Host Disease (GVHD) for the United States.GVHD is one of the severe complications associated with Hematopoietic stem cell transplantations (HSCTs). DelveInsight forecasts predict...
  3. 移植片対宿主病（GVHD）治療薬の日本市場：市場インサイト、疫学分析、市場予測
    DLVE704010 / DelveInsight / 2017年1月 / ...DelveInsight’s “Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023-Japan” report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for the forecast period (2013-2023). The report also includes global market size of the Graft Versus Host Disease (GVHD) for Japan.GVHD is one of the severe complications associated with Hematopoietic stem cell transplantations (HSCTs). DelveInsight forecasts predict an on-going increase...
  4. クローン病（CD）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06110 / DelveInsight / 2016年8月 / 当調査レポートでは、クローン病（CD）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・クローン病（CD）の概要 ・病態生理 ・クローン病（CD）の症状 ・クローン病（CD）の病因 ・クローン病（CD）の診断 ・クローン病（CD）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序... Note*: This report requires 7-10 business days to complete. DelveInsight’s Crohn’s disease (CD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Crohn’s disease (CD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Crohn’s disease (CD) till 2023. Key Coverage...
  5. ゴーシェ病（GD）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06133 / DelveInsight / 2016年8月 / 当調査レポートでは、ゴーシェ病（GD）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・ゴーシェ病（GD）の概要 ・病態生理 ・ゴーシェ病（GD）の症状 ・ゴーシェ病（GD）の病因 ・ゴーシェ病（GD）の診断 ・ゴーシェ病（GD）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序... Note*: This report requires 7-10 business days to complete. DelveInsight’s Gaucher Disease (GD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Gaucher Disease (GD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Gaucher Disease (GD) till 2023. Key Coverage and...
  6. アルツハイマー病（AD）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06098 / DelveInsight / 2016年8月 / 当調査レポートでは、アルツハイマー病（AD）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・アルツハイマー病（AD）の概要 ・病態生理 ・アルツハイマー病（AD）の症状 ・アルツハイマー病（AD）の病因 ・アルツハイマー病（AD）の診断 ・アルツハイマー病（AD）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Alzheimer’s disease (AD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Alzheimer’s disease (AD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Alzheimer’s disease (AD) till 2023. Key Coverage and Benefits • The report will help in developing...
  7. 変形性関節症（OA）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06035 / DelveInsight / 2016年9月 / 当調査レポートでは、変形性関節症（OA）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・変形性関節症（OA）の概要 ・病態生理 ・変形性関節症（OA）の症状 ・変形性関節症（OA）の病因 ・変形性関節症（OA）の診断 ・変形性関節症（OA）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Osteoarthritis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Osteoarthritis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Osteoarthritis till 2023. Key Coverage and Benefits • The report will help...
  8. 骨髄線維症（MF）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06121 / DelveInsight / 2016年8月 / 当調査レポートでは、骨髄線維症（MF）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・骨髄線維症（MF）の概要 ・病態生理 ・骨髄線維症（MF）の症状 ・骨髄線維症（MF）の病因 ・骨髄線維症（MF）の診断 ・骨髄線維症（MF）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序... Note*: This report requires 7-10 business days to complete. DelveInsight’s Myelofibrosis (MF) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Myelofibrosis (MF) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Myelofibrosis (MF) till 2023. Key Coverage and Benefits • The...
  9. 線維筋痛症（FM）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06029 / DelveInsight / 2016年9月 / 当調査レポートでは、線維筋痛症（FM）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・線維筋痛症（FM）の概要 ・病態生理 ・線維筋痛症（FM）の症状 ・線維筋痛症（FM）の病因 ・線維筋痛症（FM）の診断 ・線維筋痛症（FM）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Fibromyalgia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Fibromyalgia till 2023. Key Coverage and Benefits • The report will help...
  10. HIV関連リポジストロフィー（脂肪異栄養症）治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06019 / DelveInsight / 2016年9月 / 当調査レポートでは、HIV関連リポジストロフィー（脂肪異栄養症）治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・HIV関連リポジストロフィー（脂肪異栄養症）の概要 ・病態生理 ・HIV関連リポジストロフィー（脂肪異栄養症）の症状 ・HIV関連リポジストロフィー（脂肪異栄養症）の病因 ・HIV関連リポジストロフィー（脂肪異栄養症）の診断 ・HIV関連リポジストロフィー（脂肪異栄養症）の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 5-10 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and HIV-associated Lipodystrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of HIV-associated Lipodystrophy till 2023. Key Coverage and Benefits • The...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆